Bayer AG
XETRA:BAYN
Bayer AG
Total Current Assets
Bayer AG
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Total Current Assets
€37.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Total Current Assets
$185.6m
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Total Current Assets
€12.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
MPH Health Care AG
XETRA:93M1
|
Total Current Assets
€4.5m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Total Current Assets
€630.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Total Current Assets
€51.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Total Current Assets?
Total Current Assets
37.6B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Total Current Assets amounts to 37.6B EUR.
What is Bayer AG's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
7%
Over the last year, the Total Current Assets growth was -1%. The average annual Total Current Assets growth rates for Bayer AG have been 2% over the past three years , 4% over the past five years , and 7% over the past ten years .